In another beaten down stock some of us own, the F
Post# of 36537
(Total Views: 307)
Posted On: 10/28/2021 8:11:10 AM
In another beaten down stock some of us own, the FDA just accepted their rolling review timeline to resubmit their BLA for HIV indication.
Sure would be nice to see a Generex PR with an ‘FDA accepted’ headline. I will also take anything related to these items: IPO, Excellegan, Regentys, AltuCell, Telemedicine/ Arizona Clinic updates.
Anyone think the large volume the other day may have been another Oasis share payment immediately being sold?
If we don’t see news today, I think we can scratch Oct off the possible updates list. Refilled under ‘Totally Unacceptable’.
Sure would be nice to see a Generex PR with an ‘FDA accepted’ headline. I will also take anything related to these items: IPO, Excellegan, Regentys, AltuCell, Telemedicine/ Arizona Clinic updates.
Anyone think the large volume the other day may have been another Oasis share payment immediately being sold?
If we don’t see news today, I think we can scratch Oct off the possible updates list. Refilled under ‘Totally Unacceptable’.
(4)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼